Ongoing clinical trials are studying the efficacy of natural micronutrients, such as genistein or synthetic PPAR-α ligands for the treatment of neuropsychiatric disorders, including Alzheimer’s disease, bipolar depression, and alcoholism [26,69,70]. The gene discussed is PPARA; the disease is Alzheimer disease.